Flamel Technologies S.A. (NASDAQ:AVDL) insider Sandra L. Hatten bought 2,100 shares of the business’s stock in a transaction on Thursday, September 14th. The stock was bought at an average cost of $9.36 per share, with a total value of $19,656.00. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of Flamel Technologies S.A. (AVDL) traded up 2.06% during midday trading on Friday, hitting $9.42. 217,119 shares of the stock were exchanged. The stock has a market cap of $377.59 million, a price-to-earnings ratio of 9.95 and a beta of 1.39. The firm’s 50-day moving average is $9.04 and its 200-day moving average is $9.83. Flamel Technologies S.A. has a 12 month low of $8.14 and a 12 month high of $14.15.

Flamel Technologies (NASDAQ:AVDL) last issued its earnings results on Tuesday, August 8th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.14. Flamel Technologies had a net margin of 21.13% and a return on equity of 29.84%. The firm had revenue of $46.30 million during the quarter, compared to analysts’ expectations of $45.17 million. The business’s revenue for the quarter was up 19.0% on a year-over-year basis. Equities research analysts predict that Flamel Technologies S.A. will post $1.16 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://www.americanbankingnews.com/2017/09/15/flamel-technologies-s-a-avdl-insider-acquires-19656-00-in-stock.html.

Several institutional investors have recently modified their holdings of the stock. Janus Henderson Group PLC purchased a new position in shares of Flamel Technologies during the second quarter worth $24,100,000. Acadian Asset Management LLC raised its holdings in shares of Flamel Technologies by 9.7% during the second quarter. Acadian Asset Management LLC now owns 1,672,207 shares of the company’s stock worth $18,444,000 after purchasing an additional 147,907 shares during the last quarter. Russell Investments Group Ltd. purchased a new position in shares of Flamel Technologies during the first quarter worth $3,654,000. OxFORD Asset Management LLP raised its holdings in shares of Flamel Technologies by 62.7% during the second quarter. OxFORD Asset Management LLP now owns 334,881 shares of the company’s stock worth $3,694,000 after purchasing an additional 129,044 shares during the last quarter. Finally, GSA Capital Partners LLP raised its holdings in shares of Flamel Technologies by 9.9% during the second quarter. GSA Capital Partners LLP now owns 200,213 shares of the company’s stock worth $2,208,000 after purchasing an additional 18,056 shares during the last quarter. 69.09% of the stock is owned by hedge funds and other institutional investors.

AVDL has been the subject of a number of research analyst reports. Zacks Investment Research downgraded shares of Flamel Technologies from a “hold” rating to a “sell” rating in a research report on Monday, August 7th. Langenberg & Company reaffirmed a “buy” rating and issued a $30.00 target price (up previously from $27.00) on shares of Flamel Technologies in a research report on Thursday, September 7th. Ladenburg Thalmann Financial Services lifted their target price on shares of Flamel Technologies from $27.00 to $30.00 in a research report on Thursday, September 7th. Finally, Roth Capital set a $15.00 target price on shares of Flamel Technologies and gave the stock a “buy” rating in a research report on Wednesday, August 9th. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. Flamel Technologies has an average rating of “Buy” and a consensus target price of $19.83.

Flamel Technologies Company Profile

Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.

Insider Buying and Selling by Quarter for Flamel Technologies (NASDAQ:AVDL)

Receive News & Ratings for Flamel Technologies S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flamel Technologies S.A. and related companies with MarketBeat.com's FREE daily email newsletter.